6 septiembre 2014
An analysis of phase 2 and phase 3 clinical trials shows that a single injected dose of the neuraminidase inhibitor peramivir is safe and effective at alleviating influenza symptoms, including fever and viral shedding, when administered within 48 hours of the onset of symptoms.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Op3zjZCtCm0/140906173236.htm
